medigraphic.com

2005, Número 4

<< Anterior Siguiente >>

Rev Mex Anest 2005; 28 (4)


El riesgo del procedimiento anestésico en la función renal

Díaz de León-Ponce MA, Díaz de León-Ponce G, Moreno-Santillán AA, González-Díaz J, Briones-Garduño JC

Idioma: Español
Referencias bibliográficas: 46
Paginas: 233-238
Archivo PDF: 68.05 Kb.


RESUMEN

Se analizó la literatura nacional e internacional con el fin de revisar las alteraciones de la función renal que pueden causar los medicamentos utilizados por los médicos anestesiólogos durante el acto pre, trans y postoperatorio, y que por condiciones específicas del enfermo, dichas alteraciones pueden provocar insuficiencia renal aguda o la agudización de la insuficiencia renal crónica. Si el anestesiólogo es minucioso en el estudio de las sustancias que utiliza cotidianamente podrá detectar tempranamente la presencia de daño renal o alteraciones hemodinámicas en el paciente, con lo cual disminuirá la incidencia de los efectos adversos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lamaire N, Vanholder R. Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J Am Soc Nephrol. 2001; 12 Suppl 17: S20-32.

  2. Abernethy VE, Lieberthal W. Acute renal failure in the critically ill patient. Crit Care Clin. 2002; 18: 203-22.

  3. Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 2005; 33: 311-12.

  4. Mindell JA. A practical approach to acute renal failure. Med Clin North Am 1997; 3: 731-748.

  5. Choudhury D. Drug induced nephrotoxicity. Med Clin North Am 1997; 3: 705-775.

  6. Nolan CR. Hospital-acquired acute renal failure. J Am Soc Nephrol 1998; 4: 710-718.

  7. Kröll W. Acute renal failure - implications for the anesthesia management. Acta Anaesthesiol Scand 1996; 40: 20-22.

  8. Conzen PF, Nuscheler M, Melotte A, Verhaegen M, Leupolt T, Van Aken H, Peter K. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg 1995; 81: 569-75.

  9. Dreisbach HR. Manual de toxicología clínica. Ed. Manual Moderno. México. 1984: 198-199.

  10. Nuscheler M, Conzen P, Peter K. [Sevoflurane: metabolism and toxicity]. Anaesthesist 1998; 47 Suppl 1: S24-32.

  11. Mazze RI, Jamison R. Renal Effects of Sevoflurane. Amer Soc of Anesthesiol 1995; 3: 443-445.

  12. Tung A, Jacobsohn E. A Case of Nonoliguric Renal Failure after General Anesthesia with Sevoflurane and Desflurane. Anesth Analg 1997; 6: 1407-1409.

  13. Higuchi H, Adachi Y, Wada H, Kanno M, Satoh T. The effects of low-flow sevoflurane and isoflurane anesthesia on renal function in patients with stable moderate renal insufficiency. Anesth Analg 2001; 92: 650-5.

  14. Conzen PF, Kharasch ED, Czerner SF, Artru AA, Reichle FM, Michalowski P, Rooke GA, Weiss BM, Ebert TJ. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency. Anesthesiol 2002; 97: 578-84.

  15. Gong D, Koblin DD, Bowland T, Ionescu P, Laster MJ, Weiskopf RB. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 85: 1154-1163.

  16. Litz RJ, Hubler M, Lorenz W, Meier VK, Albrecht DM. Renal responses to desflurane and isoflurane in patients with renal insufficiency. Anesthesiol. 2002; 97: 1133-6.

  17. Zager RA, Burkhart KM, Conrad DS. Isoflurane alters proximal tubular cell susceptibility to toxic and hypoxic forms of attack. Kidney Int 1999; 55: 148-59.

  18. Higuchi H, Sumikura H, Sumita S, Arimura S, Takamatsu F, et al. Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiol 1995; 3: 449-458.

  19. Rivero SO, Tainimoto WM. Uso de los medicamentos en la clínica. Ed. McGraw-Hill Interamericana, México 1999: 18-27.

  20. Villarejo DM. PAC Anestesia-1. Farmacología aplicada a la anestesia. Editorial Intersistemas. 1998: 5-78.

  21. Walder AD. Failure of anaesthesia with etomidate. Eur J Anaesthesiol 1995; 12: 325-7.

  22. Kakinohana M, Tokumine J, Kawashima S, Koja H, Sugahara K. Patient-controlled sedation using propofol in eight patients with endstage renal failure. J Anesth 2004; 18: 39-42.

  23. Casserly B, O’Mahony E, Timm EG, Haqqie S, Eisele G, Urizar R. Propofol infusion syndrome: an unusual cause of renal failure. Am J Kidney Dis 2004; 44: e98-101.

  24. Withington DE, Decell MK, Al Ayed T. A case of propofol toxicity: further evidence for a causal mechanism. Paediatr Anaesth 2004; 14: 505-8.

  25. Wiklund RA, Rosenbaum SH. Medical progress: Anesthesiology: First of two parts. N Engl J Med 1997; 337: 1132-1141.

  26. Wouters PF, Van de Velde MA, Marcus MA, Deruyter HA, Van Aken H. Hemodynamic changes during induction of anesthesia with eltanolone and propofol in dogs. Anesth Analg 1995; 81: 125-31.

  27. Lee HT, Xu H, Siegel CD, Krichevsky IE. Local anesthetics induce human renal cell apoptosis. Am J Nephrol 2003; 23: 129-39.

  28. Lili C, Shibata N, Yoshikawa Y, Takada K. Effect of glycerol-induced acute renal failure on the pharmacokinetics of lidocaine after transdermal application in rats. Biol Pharm Bull 2003; 26: 1150-4.

  29. Rodriguez J, Quintela O, Lopez-Rivadulla M, Barcena M, Diz C, Alvarez J. High doses of mepivacaine for brachial plexus block in patients with end-stage chronic renal failure. A pilot study. Eur J Anaesthesiol 2001; 18: 171-6.

  30. Lee HT, Xu H, Siegel CD. Krichevsky IE. Local anesthetics induce human renal cell apoptosis. J Am Soc Nephrol 2003; 23: 129-39.

  31. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 2004; 28: 497-504.

  32. Hohne C, Donaubauer B, Kaisers U. [Opioids during anesthesia in liver and renal failure]. Anaesthesist 2004; 53: 291-303.

  33. Mazoit JX. [Conventional techniques for analgesia: opioids and non-opioids. Indications, adverse effects and monitoring]. Ann Fr Anesth Reanim 1998; 17: 573-84.

  34. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy 2004; 24: 776-83.

  35. Urch CE, Carr S, Minton O. A retrospective review of the use of alfentanyl in a hospital palliative care setting. Palliat Med 2004; 18: 516-9.

  36. Tuncer S, Bariskaner H, Yosunkaya A, Kilic M, Dogan N, Otelcioglu S. [The effects of sufentanyl and remifentanyl in the isolated perfused rat kidney]. Agri 2004; 16: 56-61.

  37. Cammu G. Interactions of neuromuscular blocking drugs. Acta Anaesthesiol Belg 2001; 52: 357-63. 38. Shaaban MJ, Lakkis S, Ashkar K. Succinylcholine-induced rhabdomyolysis in a healthy child. Middle East J Anesthesiol 2000; 15: 681-6.

  38. Thapa S, Brull SJ. Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg 2000; 91: 237-41.

  39. Della Rocca G, Pompei L, Coccia C, Costa MG, Cecchini V, Vilardi V, Pietropaoli P. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure. Minerva Anestesiol 2003; 69: 605-11, 612, 5.

  40. Sakamoto H, Takita K, Kemmotsu O, Morimoto Y, Mayumi T. Increased sensitivity to vecuronium and prolonged duration of its action in patients with end-stage renal failure. J Clin Anesth 2001; 13: 193-7.

  41. Chuanyao T, James CE. Adrenergic Agonists a2. Med Clin North Am 1994; 1: 51.

  42. Adnan T, Elif AA, Ayse K, Gulnaz A. Clonidine as an adjuvant for lidocaine in axillary brachial plexus block in patients with chronic renal failure. Acta Anaesthesiol Scand 2005; 49: 563-8 44. Lewis KP, Stanley GD. Pharmacology. Int Anesthesiol Clin 1999 Fall; 37: 73-86.

  43. Hauet T, Han Z, Wang Y, Hameury F, Jayle C, Gibelin H, Goujon JM, Eugene M, Papadopoulos V. Modulation of peripheral-type benzodiazepine receptor levels in a reperfusion injury pig kidney-graft model. Transplantation 2002; 74: 1507-15.

  44. Monasterolo LA, Trumper L, Elias MM. Reversal of benzodiazepine-induced renal vasculature relaxation with flumazenil. Eur J Pharmacol 2002; 449: 155-8.

  45. Bolon M, Boulieu R, Flamens C, Paulus S, Bastien O. [Sedation induced by midazolam in intensive care: pharmacologic and pharmacokinetic aspects]. Ann Fr Anesth Reanim 2002; 21: 478-92.

  46. Price G. Metformin lactic acidosis, acute renal failure and rofecoxib. Br J Anaesth 2003; 91: 909-910.




2020     |     www.medigraphic.com